PATENT CLAIM ANALYSIS

Application Number: 15765845
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "415000"]

Abstract:
A method of treating a mammalian subject with cancer comprises administering to said subject having a cancer, e.g., a metastatic or refractory cancer or tumor, a small molecule inhibitor of a target signaling molecule of the MEK/MAPK pathway that impairs T cell activation, and administering to said subject a molecule that induces T cell proliferation in the presence of said inhibitor. The combination of a small molecule inhibitor of a target of the MEK/MAPK pathway and the T cell proliferation inducer reduces the proliferation of the cancer and tumor cells in vivo. Compositions and kits including these components are also provided.

Claim (Index 3):
The method according to  claim 2 , wherein the target is MEK.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 91.0
- Lexical Diversity: 2.03774
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15661100', '15285854', '14755989', '15580991', '15776061']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8230325711148643
- 35 USC 102 Novelty (BERT): 0.5506593404513254
- Combined Prediction Score: 0.7957952480485103
- Mean Citation Score: 389.842968
- Max Citation Score: 558.65643
- Similarity Product: 254.20738009356555

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test